Atlas Trials

A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients

Clinical trial NCT02616666 · COMPLETED

Trial details

NCT number
NCT02616666
Sponsor
University of Liverpool
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2016-08-25
Primary completion
2025-12-12
Enrollment
632

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.